Charting the future of public relations
Steven Immergut To Lead US Pharmaceutical Comms For Bayer
Holmes Report
Holmes Report
News and insights from the global PR industry

Steven Immergut To Lead US Pharmaceutical Comms For Bayer

Bayer Corporation has appointed Steven Immergut to a newly created senior position leading communications for the company's pharmaceutical business in the United States.

Holmes Report

Steven Immergut To Lead US Pharmaceutical Comms For Bayer

WHIPPANY, NJ—Bayer Corporation has appointed Steven Immergut to a newly created senior position leading communications for the company's pharmaceutical business in the United States. As vice president and head of communications, Bayer HealthCare Pharmaceuticals, he will be responsible for developing and executing external and internal communication strategies for Bayer's pharmaceutical portfolio in the United States.  

Immergut spent the last three years in senior roles at the US Food and Drug Administration, most recently as acting associate commissioner for external affairs, where he directed communications and media on a wide range of regulatory and educational activities and issues, managed stakeholder relationships, and helped FDA continue to transform its website and blog

Immediately prior to his FDA role, Immergut managed government and private sector health communications activities for the management consulting firm Booz Allen Hamilton. He previously directed the Washington, DC, healthcare practice of Hill+Knowlton Strategies.

Immergut will report to Raymond Kerins, senior vice president and head of communications, government relations and policy for Bayer Corporation, and will serve on the US communications, government relations and policy leadership team. He will be based in Washington, DC, with regular travel to the company’s New Jersey headquarters. 

Article tags
In-House Bayer People News
View Style:

Load 3 More
comments powered by Disqus